Case File №
#VI-2026-0759
Paradigm Peptide
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
38 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | A Great | 6 | 9.6 | 7.6 | 10.0 | 24 Jul 2025 |
| Tirzepatide | A Great | 10 | 8.5 | 6.8 | 10.0 | 5 Aug 2025 |
| 4-Piperidone CAS 41661-47-6 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 13 Feb 2025 |
| Adipotide | X N/A | 1 | 8.1 | 8.1 | 8.1 | 28 Mar 2025 |
| Andarine S4 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 3 Jul 2025 |
| Aromasin (Exemestane) | X N/A | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 |
| Blend 500 (Tren E/Mast E) | X N/A | 1 | 9.1 | 9.1 | 9.1 | 13 Feb 2025 |
| Boldenone Cypionate | X N/A | 1 | 8.9 | 8.9 | 8.9 | 24 Apr 2025 |
| Bronchogen | X N/A | 1 | 10.0 | 10.0 | 10.0 | 7 May 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 10.0 | 10.0 | 10.0 | 3 Jul 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 8.2 | 8.2 | 8.2 | 2 Jul 2025 |
| Dianabol Oil | X N/A | 1 | 9.5 | 9.5 | 9.5 | 17 Dec 2024 |
| Dianabol | X N/A | 1 | 8.2 | 8.2 | 8.2 | 27 Feb 2025 |
| Estradiol Cypionate | X N/A | 1 | 6.7 | 6.7 | 6.7 | 3 Jul 2025 |
| Finasteride | X N/A | 1 | 7.4 | 7.4 | 7.4 | 3 Jun 2025 |
| GW-501516 (Cardarine) | X N/A | 1 | 10.0 | 10.0 | 10.0 | 20 Jun 2025 |
| HMG | X N/A | 1 | 8.6 | 8.6 | 8.6 | 16 Mar 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 7.3 | 7.3 | 7.3 | 3 Jun 2025 |
| KPV Oral | X N/A | 1 | 8.4 | 8.4 | 8.4 | 3 Jun 2025 |
| LGD-4033 (Ligandrol) Raw | X N/A | 1 | 5.4 | 5.4 | 5.4 | 2 Jul 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 |
| Liraglutide | X N/A | 1 | 9.4 | 9.4 | 9.4 | 21 May 2025 |
| MOTS-C | X N/A | 1 | 10.0 | 10.0 | 10.0 | 14 Jan 2025 |
| NA Semax Amidate | X N/A | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 |
| NAD+ | X N/A | 1 | 8.2 | 8.2 | 8.2 | 7 May 2025 |
| Nandrolone Decanoate (Deca) Raw | X N/A | 1 | 7.5 | 7.5 | 7.5 | 3 Jul 2025 |
| Nandrolone Phenylpropionate (NPP) Raw | X N/A | 1 | 9.9 | 9.9 | 9.9 | 11 Jun 2025 |
| NandroMix 300 | X N/A | 1 | 7.6 | 7.6 | 7.6 | 8 Jul 2025 |
| NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | X N/A | 1 | 8.1 | 8.1 | 8.1 | 3 Jun 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 9.6 | 9.6 | 9.6 | 28 Mar 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 |
| SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | X N/A | 1 | 8.5 | 8.5 | 8.5 | 3 Jul 2025 |
| TB-500 FRAG | X N/A | 1 | 8.5 | 8.5 | 8.5 | 3 Jun 2025 |
| Tren Base | X N/A | 1 | 6.5 | 6.5 | 6.5 | 24 Apr 2025 |
| TriTren 225 | X N/A | 1 | 8.9 | 8.9 | 8.9 | 14 Jan 2025 |
| Winstrol Oil | X N/A | 1 | 9.3 | 9.3 | 9.3 | 14 Jan 2025 |
Exhibit II
Evidence Log
43 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 9.6 A | 10mg | 10.3mg | +3.0% | 96.44% | 2t46oy | Lab B | Public |
| 24 May 2026 | TB-500 FRAG | 9.7 A | 10mg | 11.3mg | +13.3% | 98.12% | 9fmazf | Lab F | Public |
| 24 May 2026 | GW-501516 (Cardarine) | 10.0 A | 20mg | 18.5mg | -7.7% | 98.37% | cr8k5g | Lab F | Public |
| 24 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.7 A | 15mg | 18.0mg | +20.1% | 95.35% | vds0pd | Lab F | Public |
| 24 May 2026 | NA Semax Amidate | 10.0 A | 20mg | 17.8mg | -10.9% | 95.75% | eqsgsy | Lab G | Community |
| 24 May 2026 | KPV Oral | 10.0 A | 20mg | 17.3mg | -13.6% | 97.37% | uujo79 | Lab B | Public |
| 24 May 2026 | Tren Base | 5.6 B | 200mg/ml | 245.2mg/ml | +22.6% | 95.69% | ifpx1o | Lab D | Public |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 10.0 A | 10mg | 9.0mg | -10.3% | 98.97% | tyzm57 | Lab G | Public |
| 23 May 2026 | Aromasin (Exemestane) | 10.0 A | 20mg | 17.7mg | -11.3% | 97.54% | wt5967 | Lab G | Public |
| 23 May 2026 | NAD+ | 6.9 A | 20mg | 18.1mg | -9.7% | 98.88% | gd61ct | Lab C | Community |
| 21 May 2026 | Blend 500 (Tren E/Mast E) | 9.3 A | 100mg/ml | 86.1mg/ml | -13.9% | 98.62% | bfg3dp | Lab G | Community |
| 21 May 2026 | Nandrolone Decanoate (Deca) Raw | 8.1 A | 100g | 88.1g | -11.9% | 98.16% | 9lkqog | Lab C | Public |
| 21 May 2026 | TriTren 225 | 8.1 A | 250mg/ml | 265.2mg/ml | +6.1% | 95.08% | x2j4wm | Lab A | Public |
| 19 May 2026 | Nandrolone Phenylpropionate (NPP) Raw | 8.9 A | 5g | 4.7g | -5.2% | 96.52% | smumc3 | Lab G | Community |
| 17 May 2026 | Estradiol Cypionate | 10.0 A | 100mg/ml | 120.6mg/ml | +20.6% | 97.15% | 0bawjk | Lab F | Community |
| 26 Jan 2026 | Tirzepatide | 7.9 A | 60mg | 67.7mg | +12.8% | 99.90% | yh7585 | Lab G | Public |
| 26 Jan 2026 | Tirzepatide | 7.0 A | 30mg | 36.2mg | +20.7% | 99.90% | jc7585 | Lab G | Public |
| 26 Jan 2026 | LGD-4033 (Ligandrol) | 7.6 A | 20mg | 17.1mg | -14.7% | 99.79% | fng2sm | Lab G | Community |
| 22 Jan 2026 | Tirzepatide | 8.5 A | 20mg | 21.8mg | +9.0% | 99.80% | Yh7585 | Lab G | Public |
| 22 Jan 2026 | Tirzepatide | 8.5 A | 10mg | 10.8mg | +8.0% | 99.70% | jc7585 | Lab G | Public |
| 22 Jan 2026 | Tirzepatide | 8.9 A | 5mg | 5.3mg | +6.0% | 99.60% | jc7585 | Lab G | Public |
| 22 Jan 2026 | Tirzepatide | 9.4 A | 30mg | 31.8mg | +6.0% | 99.80% | jc7585 | Lab G | Public |
| 22 Jan 2026 | Tirzepatide | 7.9 A | 60mg | 67.6mg | +12.7% | 99.90% | Yh7585 | Lab G | Public |
| 19 Jan 2026 | Dianabol Oil | 7.0 A | 300mg/ml | 337.3mg/ml | +12.4% | 96.77% | d5xjrw | Lab E | Public |
| 9 Jan 2026 | Proviron (Mesterolone) | 7.2 A | 20mg | 17.3mg | -13.6% | 96.39% | 4akq41 | Lab F | Community |
| 9 Jan 2026 | Winstrol Oil | 7.7 A | 300mg/ml | 349.3mg/ml | +16.4% | 98.92% | jwj43f | Lab G | Public |
| 7 Jan 2026 | Adipotide | 6.0 A | 30mg | 33.3mg | +11.0% | 98.49% | 2s8ecr | Lab A | Public |
| 7 Jan 2026 | Dianabol | 10.0 A | 100mg | 110.4mg | +10.4% | 97.38% | dqnyof | Lab F | Public |
| 7 Jan 2026 | LGD-4033 (Ligandrol) Raw | 5.1 B | 500g | 575.1g | +15.0% | 97.85% | tzyk48 | Lab D | Community |
| 6 Jan 2026 | HMG | 9.1 A | 50mg | 51.2mg | +2.4% | 98.70% | 8uenji | Lab F | Public |
| 29 Dec 2025 | Retatrutide 30mg Pen Kit | 10.0 A | 5mg | 4.4mg | -12.3% | 97.87% | idfntr | Lab D | Public |
| 12 Dec 2025 | Ostarine (MK-2866) | 10.0 A | 25mg | 25.0mg | -0.0% | 97.11% | svc9at | Lab D | Public |
| 5 Dec 2025 | 4-Piperidone CAS 41661-47-6 | 8.2 A | 1g | 1.0g | +0.8% | 98.43% | e4qeux | Lab D | Public |
| 23 Nov 2025 | NPP (N-phenethyl-4-piperidone) CAS 39742-60-4 | 10.0 A | 10g | 9.8g | -2.3% | 96.24% | nyot6t | Lab G | Community |
| 17 Nov 2025 | Finasteride | 6.3 A | 10mg | 9.2mg | -8.4% | 98.81% | vgas1g | Lab C | Community |
| 14 Nov 2025 | Bronchogen | 10.0 A | 15mg | 17.1mg | +13.8% | 95.73% | br2l2l | Lab F | Public |
| 14 Nov 2025 | Liraglutide | 8.3 A | 5mg | 5.6mg | +12.6% | 97.55% | xl405i | Lab E | Community |
| 14 Nov 2025 | NandroMix 300 | 8.3 A | 250mg/ml | 228.6mg/ml | -8.6% | 95.41% | tilplz | Lab E | Public |
| 14 Nov 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 10.0 A | 30mg | 33.2mg | +10.7% | 95.93% | hcm3g1 | Lab F | Public |
| 5 Nov 2025 | Boldenone Cypionate | 9.0 A | 250mg/ml | 227.0mg/ml | -9.2% | 97.07% | 4252ih | Lab E | Public |
| 5 Nov 2025 | SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | 7.7 A | 100mg/ml | 120.0mg/ml | +20.0% | 95.74% | l2izts | Lab A | Public |
| 3 Oct 2025 | Andarine S4 | 7.5 A | 25mg | 25.3mg | +1.0% | 97.76% | 789che | Lab E | Public |
| 3 Oct 2025 | MOTS-C | 9.7 A | 50mg | 56.1mg | +12.2% | 95.67% | l030oj | Lab E | Public |
— END OF EVIDENCE LOG —